Tobacco use remains the leading preventable cause of death worldwide. In particular,
people with mental illness are disproportionately affected with high smoking prevalence; …

Abstract Background and Aims Despite decades of research on co‐occurring smoking and
depression, cessation rates remain consistently lower for depressed smokers than for …

Objectives The primary objectives of these international guidelines were to provide a global
audience of clinicians with (a) a series of evidence-based recommendations for the …

Background: Smoking and depression are both leading causes of disability, mortality and
morbidity around the world. Using epidemiologic data to study the association between …

Even though individuals with psychiatric conditions have a prevalence of smoking
approximately 2–4 times greater than the general population, surprisingly little evidence …

The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …

Major depressive disorder (MDD) and substance use disorders (SUDs) are prevalent,
disabling, and challenging illnesses for which new treatment options are needed …

The high prevalence of cigarette smoking and tobacco related morbidity and mortality in
people with chronic mental illness is well documented. This review summarizes results from …

Background Individuals with current or past depression are often smokers who are more
nicotine dependent, more likely to suffer from negative mood changes after nicotine …

Patients with obstructive lung diseases display abnormal circadian rhythms in lung function.
We determined the mechanism whereby environmental tobacco/cigarette smoke (CS) …